AJANTPHARM

Ajanta Pharma Share Price

₹2,706.10 -59.7 (-2.16%)

01 May, 2025 15:32

SIP TrendupStart SIP in AJANTPHARM

Start SIP

Performance

  • Low
  • ₹2,680
  • High
  • ₹2,781
  • 52 Week Low
  • ₹2,111
  • 52 Week High
  • ₹3,485
  • Open Price₹2,781
  • Previous Close₹2,766
  • Volume96,395

Investment Returns

  • Over 1 Month + 3.17%
  • Over 3 Month + 0.43%
  • Over 6 Month -11.7%
  • Over 1 Year + 22.15%
SIP Lightning

Smart Investing Starts Here Start SIP with Ajanta Pharma for Steady Growth!

Invest Now

Ajanta Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 36.7
  • PEG Ratio
  • 2.9
  • Market Cap Cr
  • 33,803
  • P/B Ratio
  • 9.2
  • Average True Range
  • 101.37
  • EPS
  • 73.68
  • Dividend Yield
  • 1
  • MACD Signal
  • 20.19
  • RSI
  • 53.73
  • MFI
  • 77.36

Ajanta Pharma Financials

Ajanta Pharma Technicals

EMA & SMA

Current Price
₹2,706.10
-59.7 (-2.16%)
pointer
  • stock-down_img
  • Bearish Moving Average 7
  • stock-up_img
  • Bullish Moving Average 9
  • 20 Day
  • ₹2,666.11
  • 50 Day
  • ₹2,658.97
  • 100 Day
  • ₹2,708.04
  • 200 Day
  • ₹2,688.95

Resistance and Support

2722.43 Pivot Speed
  • R3 2,866.67
  • R2 2,824.03
  • R1 2,765.07
  • S1 2,663.47
  • S2 2,620.83
  • S3 2,561.87

What's your outlook on Ajanta Pharma?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ajanta Pharma is a specialty pharmaceutical company offering innovative, high-quality medicines across 30+ countries. With leadership in multiple therapeutic segments, Ajanta operates 7 state-of-the-art manufacturing facilities, supported by robust R&D capabilities and a strong global presence.

Ajanta Pharma has an operating revenue of Rs. 4,531.77 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 26% is great, ROE of 22% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and around 6% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 22% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 69 which is a FAIR score but needs to improve its earnings, a RS Rating of 73 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 51 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ajanta Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-04-30 Audited Results & A.G.M.
2025-01-30 Quarterly Results
2024-10-28 Quarterly Results
2024-07-30 Quarterly Results
2024-05-02 Audited Results & Buy Back of Shares
Date Purpose Remarks
2024-11-06 INTERIM Rs.28.00 per share(1400%)First Interim Dividend
2024-02-08 INTERIM Rs.26.00 per share(1300%)Second Interim Dividend
2023-08-04 SPECIAL Rs.15.00 per share(750%)Special Dividend
2023-08-04 INTERIM Rs.10.00 per share(500%)First Interim Dividend
2022-11-14 INTERIM Rs.7.00 per share(350%)Interim Dividend
View More
Date Purpose Remarks
2022-06-23 Bonus Rs.0.00 issue in the ratio of 1:2 of Rs. 2/-.

Ajanta Pharma F&O

Ajanta Pharma Shareholding Pattern

66.26%
15.13%
1.58%
8.86%
0%
6.63%
1.54%

About Ajanta Pharma

  • NSE Symbol
  • AJANTPHARM
  • BSE Symbol
  • 532331
  • Managing Director
  • Mr. Yogesh M Agrawal
  • ISIN
  • INE031B01049

Similar Stocks to Ajanta Pharma

Ajanta Pharma FAQs

Ajanta Pharma share price is ₹2,706 As on 01 May, 2025 | 15:18

The Market Cap of Ajanta Pharma is ₹33802.5 Cr As on 01 May, 2025 | 15:18

The P/E ratio of Ajanta Pharma is 36.7 As on 01 May, 2025 | 15:18

The PB ratio of Ajanta Pharma is 9.2 As on 01 May, 2025 | 15:18

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23